相关实验视频

Updated: May 3, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

通过Cu PET/MRI可视化的威尔逊病老鼠模型中,甲诺巴迅速促进胆管铜的分泌

Emilie Munk Lynderup^1,2, Mikkel Holm Vendelbo^3,4, Frederik Teicher Kirk^1,2

¹Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

British journal of pharmacology

|September 2, 2025

概括

在威尔逊病的老鼠模型中,甲诺巴恢复了胆管中的铜分泌. ARBM101显示出显著的疗效,表明对威尔逊病的治疗潜力.

科学领域:

生物化学
医学成像
药理学

背景情况:

威尔逊病是一种影响铜代谢的遗传性疾病.
甲诺巴克是具有潜在治疗用途的结合铜.
LPP Atp7b-/ - - 鼠标模型模仿了人类的威尔逊病理.

研究的目的:

在威尔逊病小鼠模型中评估两种甲巴克ARBM101和MB-OB3b在恢复铜处理方面的疗效.
为了比较甲巴治疗与已知治疗方法,
使用64CuPET/MRI研究铜运输机制.

主要方法:

在LPP Atp7b^-小鼠中使用Cu正子发射断层扫描/磁共振成像 (PET/MRI) 来追踪铜的分布.
小鼠接受静脉注射⁶⁴Cu,随后进行腹膜内注射盐溶液,青胺,MB-OB3b或ARBM101.
在肝脏,脏和腹部和骨盆区域的铜水平 (注射剂量%) 在24小时内得到量化.

主要成果:

与基线对照相比,LPP大鼠的肝脏积量显著增加.
在LPP大鼠中没有胆汁分泌,但在对照群中存在.
甲巴治疗,特别是ARBM101,促进了小肠中的Cu的出现,这表明胆道分泌恢复了.
在24小时内,ARBM101治疗几乎使肝脏Cu水平正常化.

结论:

在威尔逊病的小鼠模型中,单剂量甲巴丁有效地恢复了胆管中的铜分泌.
与MB-OB3b相比,ARBM101在正常化铜处理方面表现出更高的效率.
这些发现表明甲巴,特别是ARBM101,对威尔逊病具有显著的治疗前景.

关键词:

化疗法阳离子发射断层扫描铜的代谢铜结合蛋白

更多相关视频

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

相关概念视频

Hepatic Drug Excretion: Enterohepatic Cycling

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

Hepatic Drug Excretion: Influencing Factors

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...